• About Us
    • List of Regulators
    • News Websites
  • What We Do
    • Downloads
  • Mission
  • Vision
  • Contact Us
  • Terms of use
  • Privacy Policy
  • Disclaimer
Investadvocate
  • Home
  • Business News
    • Capital Market
    • Money Market
    • Fraud & Scandals
    • Results & Dividends
  • Updates
  • Investors Bite
  • World News
  • Trending
  • Over-the-Counter Beat
  • Q & A Session

All Posts in "Capital Market"

Mecure Industries to List on NGX’s Main Board at N2.96 Per Share

Mecure Industries to List on NGX’s Main Board at N2.96 Per Share

November 6, 2023/NGX Mecure Industries Limited, a leading human pharmaceuticals and nutraceuticals manufacturing company will…
by InvestAdvocate — November 6, 2023 in Capital Market 0
MCB Capital Markets advises EnVolt on its inaugural Green Project Bond issue

MCB Capital Markets advises EnVolt on its inaugural Green Project Bond issue

It is the first time that a renewable energy project is financed by a bond…
by InvestAdvocate — November 6, 2023 in Capital Market 0
We Have Sufficient Stock of Currency Notes

We Have Sufficient Stock of Currency Notes

November 3, 2023/NGX The attention of the Central Bank of Nigeria (CBN) has been drawn…
by InvestAdvocate — November 3, 2023 in Capital Market 0

Posts pagination

Previous 1 … 56 57 58 … 1,054 Next
WEEKLY TOP GAINERS
COYOPENING PRICECLOSING PRICE% CHG
UPDCREIT 10.65 14.20+33.33%
FBNH959.95120.50+25.59%
UNILEVER124.00147.95+19.31%
CADBURY   57.00  67.50+18.42%
AXAMANS    11.20   13.20+17.86%
WEEKLY TOP LOSERS
COYOPENING PRICECLOSING PRICE% CHG
MECURE85.4562.40-26.97%
ROYALEX   1.48  1.29-12.84%
TRIPLGE    3.89   3.41-12.34%
SUNUASR    4.00     3.60-10.00%
BUAFOODS939.00845.10-10.00%

Source: NGX as at July 24, 2026

APO NEWSROOM

Follow Investadvocate on Twitter

Tweets by @investadvocate

Regulators Links

 

NGX

SEC

CBN

EFCC

CSCS

NDIC

MORE

 

TV Stations

 

CNN

AlJazeera

TVC News

AIT

Channels TV

BBC

CNBC

News Websites

 

Yahoo! News 

Premier League

The Will 

Proshare

Huhuonline

Financial Times 

More

 

opan

 

 

© 2026 Investadvocate ·